Literature DB >> 28740644

The hemodynamic impact of acute nasal continuous positive airway pressure treatment in hypertrophic cardiomyopathy: is it safe?

Bo Xu1, Reena Mehra2.   

Abstract

Entities:  

Year:  2017        PMID： 28740644      PMCID： PMC5506135          DOI： 10.21037/jtd.2017.05.20

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   3.005


× No keyword cloud information.
  13 in total

Review 1.  Cardiovascular effects of mechanical ventilation.

Authors:  L Shekerdemian; D Bohn
Journal:  Arch Dis Child       Date:  1999-05       Impact factor: 3.791

Review 2.  Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy.

Authors:  Barry J Maron
Journal:  Circulation       Date:  2010-01-26       Impact factor: 29.690

3.  Acute Effects of Nasal CPAP in Patients With Hypertrophic Cardiomyopathy.

Authors:  Flávia B Nerbass; Vera M C Salemi; Rodrigo P Pedrosa; Natanael de P Portilho; Julio C A Ferreira-Filho; Henrique T Moriya; Murillo O Antunes; Edmundo Arteaga-Fernández; Luciano F Drager; Geraldo Lorenzi-Filho
Journal:  Chest       Date:  2016-05-07       Impact factor: 9.410

Review 4.  Hypertrophic cardiomyopathy.

Authors:  Barry J Maron; Martin S Maron
Journal:  Lancet       Date:  2012-08-06       Impact factor: 79.321

Review 5.  Quantitative assessment of mitral regurgitation: how best to do it.

Authors:  Paaladinesh Thavendiranathan; Dermot Phelan; Patrick Collier; James D Thomas; Scott D Flamm; Thomas H Marwick
Journal:  JACC Cardiovasc Imaging       Date:  2012-11

6.  Obstructive sleep apnea is common and independently associated with atrial fibrillation in patients with hypertrophic cardiomyopathy.

Authors:  Rodrigo P Pedrosa; Luciano F Drager; Pedro R Genta; Aline C S Amaro; Murillo O Antunes; Afonso Y Matsumoto; Edmundo Arteaga; Charles Mady; Geraldo Lorenzi-Filho
Journal:  Chest       Date:  2010-02-12       Impact factor: 9.410

7.  Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.

Authors:  P M Elliott; J Poloniecki; S Dickie; S Sharma; L Monserrat; A Varnava; N G Mahon; W J McKenna
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

8.  High prevalence of abnormal nocturnal oximetry in patients with hypertrophic cardiomyopathy.

Authors:  Mackram F Eleid; Tomas Konecny; Marek Orban; Partho P Sengupta; Virend K Somers; James M Parish; Farouk Mookadam; Peter A Brady; Barbara L Sullivan; Bijoy K Khandheria; Steve R Ommen; A Jamil Tajik
Journal:  J Am Coll Cardiol       Date:  2009-11-03       Impact factor: 24.094

9.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Iacopo Olivotto; Sandro Betocchi; Susan A Casey; John R Lesser; Maria A Losi; Franco Cecchi; Barry J Maron
Journal:  N Engl J Med       Date:  2003-01-23       Impact factor: 91.245

Review 10.  Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging.

Authors:  Patrizio Lancellotti; Christophe Tribouilloy; Andreas Hagendorff; Bogdan A Popescu; Thor Edvardsen; Luc A Pierard; Luigi Badano; Jose L Zamorano
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2013-06-03       Impact factor: 6.875
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.